As a member, Memorial Healthcare will actively help develop standards of care for integrating molecular profiling in oncology while attempting to increase patient access to personalized medicine in clinical settings.
The hospital system will also have access to Caris’ multiple technology profiling system to help physicians identify therapy options and clinical trial opportunities based on the unique characteristics of a patient’s tumor, according to Caris officials.
More articles on transactions and valuations:
Charlotte Hungerford, Hartford HealthCare boards agree to affiliate
Prospect finalizes $335M acquisition of 3 hospitals
Our Lady of the Lake Regional buys majority interest in surgical hospital
